TSHA
Taysha Gene Therapies Inc
4.50$
+1.4%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +10.6% | -11.2% | -0.9% | -8.7% | +3.4% | -6.9% | -2.1% | +3.2% | +4.5% | -1.3% | -1.4% | – | |
| – | -3.5% | +62.5% | +4.2% | +0.8% | -4.2% | +2.4% | -3.2% | +3.0% | +7.4% | +57.2% | +4.7% | – | |
| – | – | – | -1,536.9% | – | – | – | – | +81.1% | -275.4% | – | – | – | |
| – | -99.5% | +723.5% | +43.6% | -82.6% | -94.3% | +18,800.0% | -99.5% | +5,300.0% | +131.5% | +1,109.6% | -100.0% | – | |
| – | -99.7% | +1,300.0% | +43.6% | -82.6% | – | -2,953.8% | – | -177.4% | +414.6% | +1,124.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -103.0% | -99.5% | – | -90.6% | -105.4% | -85.4% | – | -95.9% | +463.3% | -98.6% | +30,371.9% | – | |
| – | -117.1% | – | – | -130.9% | – | – | – | -107.9% | – | -291.2% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.